Audited information

Clariant has grouped its activities into four (reportable segments): Care Chemicals (BU ICS), Catalysis (BU ), Natural Resources (BU Oil & Mining Services, BU Functional Minerals) and Plastics & Coatings (BU , BU , BU ). The Energy Storage business which pertained to the BA Catalysis was sold in 2015.

Intersegment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.

Segment assets consist of property, plant and equipment, goodwill, intangible assets, inventories, receivables and investments in associates. They exclude deferred tax assets, financial assets and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities and corporate borrowings. Capital expenditure comprises additions to property, plant and equipment and intangibles.

Enlarge table

(XLS:) Download

Segments in CHF m

 

  

Care Chemicals

  

Catalysis

  

Natural Resources

  

Plastics & Coatings

  

Corporate

  

Total Group

 

  

2016

  

2015

  

2016

  

2015

  

2016

  

2015

  

2016

  

2015

  

2016

  

2015

  

2016

  

2015

1

EBITDA is earning before interest, tax, depreciation and amortization.

Segment sales

  

1 473

  

1 446

  

673

  

704

  

1 190

  

1 219

  

2 547

  

2 458

  

—

  

—

  

5 883

  

5 827

Sales to other segments

  

–8

  

–1

  

—

  

—

  

–6

  

–2

  

–22

  

–17

  

—

  

—

  

–36

  

–20

Total sales

  

1 465

  

1 445

  

673

  

704

  

1 184

  

1 217

  

2 525

  

2 441

  

—

  

—

  

5 847

  

5 807

Operating expenses

  

–1 254

  

–1 225

  

–571

  

–565

  

–1 039

  

–1 044

  

–2 256

  

–2 230

  

–215

  

–247

  

–5 335

  

–5 311

Thereof:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Income from associates and joint ventures

  

9

  

9

  

13

  

18

  

12

  

9

  

34

  

30

  

17

  

11

  

85

  

77

Gain/loss from disposals not qualifying as discontinued operations

  

—

  

—

  

—

  

12

  

—

  

3

  

–2

  

—

  

–1

  

—

  

–3

  

15

Restructuring, impairment and transaction-related costs

  

–10

  

–6

  

–11

  

—

  

–14

  

–1

  

–18

  

–23

  

–54

  

–85

  

–107

  

–115

Operating income

  

211

  

220

  

102

  

139

  

145

  

173

  

269

  

211

  

–215

  

–247

  

512

  

496

Net financial expenses and taxes

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

–249

  

–269

Net result from continuing operations

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

263

  

227

Result from discontinued operations

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

—

  

12

Net income

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

263

  

239

Segment assets

  

1 096

  

982

  

1 673

  

1 631

  

1 296

  

872

  

1 693

  

1 700

  

 

  

 

  

5 758

  

5 185

Segment liabilities

  

–206

  

–200

  

–95

  

–123

  

–135

  

–109

  

–249

  

–228

  

 

  

 

  

–685

  

–660

Net operating assets

  

890

  

782

  

1 578

  

1 508

  

1 161

  

763

  

1 444

  

1 472

  

—

  

—

  

5 073

  

4 525

Net assets held for sale

  

—

  

—

  

5

  

—

  

—

  

—

  

2

  

2

  

—

  

—

  

7

  

2

Corporate assets without cash

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

1 275

  

1 333

  

1 275

  

1 333

Corporate liabilities without financial liabilities

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

–2 269

  

–2 054

  

–2 269

  

–2 054

Net debt (see )

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

–1 540

  

–1 312

  

–1 540

  

–1 312

Total net assets

  

890

  

782

  

1 583

  

1 508

  

1 161

  

763

  

1 446

  

1 474

  

–2 534

  

–2 033

  

2 546

  

2 494

Thereof:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Investments in PPE and intangibles for the period

  

79

  

97

  

87

  

148

  

40

  

33

  

82

  

78

  

48

  

45

  

336

  

401

Investments in associates and joint ventures at the end of the period

  

56

  

57

  

193

  

187

  

14

  

15

  

148

  

143

  

105

  

184

  

516

  

586

Reconciliation of key figures

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Operating income

  

211

  

220

  

102

  

139

  

145

  

173

  

269

  

211

  

–215

  

–247

  

512

  

496

Add: systematic depreciation of PPE

  

49

  

42

  

30

  

33

  

27

  

24

  

69

  

68

  

35

  

36

  

210

  

203

Add: impairment

  

—

  

—

  

5

  

—

  

—

  

—

  

3

  

13

  

—

  

1

  

8

  

14

Add: amortization of intangible assets

  

6

  

4

  

17

  

17

  

14

  

11

  

10

  

11

  

8

  

11

  

55

  

54

EBITDA1

  

266

  

266

  

154

  

189

  

186

  

208

  

351

  

303

  

–172

  

–199

  

785

  

767

Add: restructuring, impairment and transaction-related costs

  

10

  

6

  

11

  

—

  

14

  

1

  

18

  

23

  

54

  

85

  

107

  

115

Less: impairment

  

—

  

—

  

–5

  

—

  

—

  

—

  

–3

  

–13

  

—

  

–1

  

–8

  

–14

Less: gain/loss from disposals not qualifying as discontinued operations

  

—

  

—

  

—

  

–12

  

—

  

–3

  

2

  

—

  

1

  

—

  

3

  

–15

EBITDA before exceptional items

  

276

  

272

  

160

  

177

  

200

  

206

  

368

  

313

  

–117

  

–115

  

887

  

853

Operating income

  

211

  

220

  

102

  

139

  

145

  

173

  

269

  

211

  

–215

  

–247

  

512

  

496

Add: restructuring, impairment and transaction-related costs

  

10

  

6

  

11

  

—

  

14

  

1

  

18

  

23

  

54

  

85

  

107

  

115

Less: gain/loss from disposals not qualifying as discontinued operations

  

—

  

—

  

—

  

–12

  

—

  

–3

  

2

  

—

  

1

  

—

  

3

  

–15

Operating income before exceptional items

  

221

  

226

  

113

  

127

  

159

  

171

  

289

  

234

  

-160

  

-162

  

622

  

596

(XLS:) Download

Reconciliation of segment assets to total assets in CHF m

 

  

31.12.2016

  

31.12.2015

Segment assets

  

5 758

  

5 185

Segment assets reported as assets held for sale

  

7

  

2

Corporate assets without cash

  

1 275

  

1 333

Cash

  

1 043

  

789

Near-cash assets

  

277

  

152

Financial instruments with positive fair values

  

5

  

—

Total Assets

  

8 365

  

7 461

(XLS:) Download

Geographic information in CHF m

 

  

Sales1

  

Non-current assets2

 

  

2016

  

2015

  

31.12.2016

  

31.12.2015

1

Allocated by region of third-party sale’s destination.

2

Non-current assets exclude deferred tax assets and pension plan assets.

EMEA

  

2 423

  

2 336

  

2 368

  

2 484

of which Germany

  

672

  

654

  

1 470

  

1 559

of which Switzerland

  

36

  

38

  

512

  

574

of which MEA

  

419

  

405

  

74

  

71

North America

  

1 120

  

1 077

  

1 321

  

893

of which USA

  

1 030

  

981

  

1 299

  

872

Latin America

  

846

  

1 021

  

253

  

224

of which Brazil

  

327

  

336

  

156

  

110

Asia/Pacific

  

1 458

  

1 373

  

550

  

495

of which China

  

474

  

450

  

185

  

217

of which India

  

182

  

159

  

103

  

63

Total

  

5 847

  

5 807

  

4 492

  

4 096

All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible.

For a description of the Business Units see .

Business area

In 2013 Clariant adjusted its reporting segments and grouped its businesses with similar end-user markets and growth drivers into four distinct Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. VIEW ENTIRE GLOSSARY

Catalyst

A substance that lowers the activation energy, thereby increasing the rate of a chemical reaction without being consumed by the reaction itself (Clariant Business Unit Catalysts). VIEW ENTIRE GLOSSARY

Additive

A substance added to products in small quantities to achieve certain properties or to improve a product (Clariant Business Unit Additives). VIEW ENTIRE GLOSSARY

Masterbatches

These are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. VIEW ENTIRE GLOSSARY

Pigment

Pigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. VIEW ENTIRE GLOSSARY

FURTHER READING